NAD+ reverses age-related muscle loss: the finding that reframes aging science

A study published in Nature Metabolism demonstrates that restoring NAD+ levels in aged mice reverses key markers of sarcopenia, opening an unprecedented window toward intervening in age-related muscle decline. The findings validate what longevity researchers have long theorized: that mitochondrial metabolic decline is not inevitable, but reversible through reactivation of cellular energy pathways. This conclusion transforms the logic of three human supplementation strategies already available in the premium biohacking market—NMN, NR, and intravenous NAD+ therapy—from mere preventive adjuncts into potentially regenerative interventions. For those seeking not only to add years to life but muscle and function to those years, this represents the first rigorous clinical evidence supporting the protocol.